Development of Humanized Ossicles: Bridging the Hematopoietic Gap.
bone marrow niche
bone tissue engineering
hematopoiesis
hematopoietic stem cells
humanized ossicle
mesenchymal stromal cells
Journal
Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
25
11
2019
revised:
16
01
2020
accepted:
31
01
2020
entrez:
30
5
2020
pubmed:
30
5
2020
medline:
9
7
2021
Statut:
ppublish
Résumé
Ectopic 'humanized ossicles' (hOss) are miniaturized, engineered human bone organs in mice displaying a similar structure and function to native mouse bones. However, they are composed of human mesenchymal derived cells forming a humanized bone marrow niche. This in vivo reconstitution of human skeletal and hematopoietic compartments provides an opportunity to investigate the cellular and molecular processes involved in their establishment and functions in a human setting. However, current hOs strategies vary in their engineering methods and their downstream applications, undermining comprehensive exploitation of their potential. This review describes the specificities of the hOs models and highlights their potential and limits. Ultimately, we propose directions for the development of hOss as a technological platform for human hematopoietic studies.
Identifiants
pubmed: 32470383
pii: S1471-4914(20)30044-7
doi: 10.1016/j.molmed.2020.01.016
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
552-569Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.